As we look at the diagnostic trends of 2026, the demand for non-invasive testing is driving a surge in the use of surface markers for "liquid biopsies." By detecting specific antigens on circulating tumor cells (CTCs) found in the blood, clinicians can now monitor cancer progression without the need for painful and risky surgical biopsies. The Cell Surface Markers Market is playing a pivotal...

According to the latest report published by Data Bridge Market Research, the Multi-Cancer Early Detection Market The global multi-cancer early detection market size was valued at USD 2.65 billion in 2024 and is expected to reach USD 8.13 billion by 2032, at a CAGR of 15.02% during the forecast period Market research analysis and data in this Multi-Cancer Early Detection...

According to the latest report published by Data Bridge Market Research, the Multi-Cancer Early Detection Market The global multi-cancer early detection market size was valued at USD 2.65 billion in 2024 and is expected to reach USD 8.13 billion by 2032, at a CAGR of 15.02% during the forecast period Market research analysis and data in this Multi-Cancer Early Detection...

According to the latest report published by Data Bridge Market Research, the Multi-Cancer Early Detection Market The global multi-cancer early detection market size was valued at USD 2.65 billion in 2024 and is expected to reach USD 8.13 billion by 2032, at a CAGR of 15.02% during the forecast period With the effectual use of technology, innovative applications and expertise,...

Oncology biomarker testing in precision medicine — the molecular profiling of tumors to match patients with targeted therapies, immunotherapies, and clinical trials representing the largest and fastest-growing application segment — creates the most clinically transformative market opportunity, with the Precision Medicine Market reflecting oncology biomarker testing as the premium...